Athanor Capital, LP Mersana Therapeutics, Inc. Transaction History

Athanor Capital, LP

  • $24.6 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$15.31 - $26.52 $230,461 - $399,205
-15,053 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$16.84 - $27.59 $253,492 - $415,312
15,053 New
15,053 $401,000
Q3 2020

Nov 16, 2020
SELL
$16.2 - $25.7 $394,065 - $625,152
-24,325 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$5.24 - $23.4 $127,463 - $569,205
24,325 New
24,325 $569,000

Others Institutions Holding MRSN

# of Institutions
125
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $72.9M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Athanor Capital, LP Portfolio

Follow Athanor Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athanor Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email